Access to hep C treatment reducing morbidity and mortality among people who inject drugs
Preclinical study: Three-step treatment strategy for pancreatic cancer
11 July 2022Intensive telephone-based cessation counseling results in improved smoking quit rates
12 July 2022Access to hep C treatment reducing morbidity and mortality among people who inject drugs
A longitudinal cohort study of persons with a history of injection drug use has found that more people who inject drugs (PWID) are receiving Hepatitis C virus (HCV) treatment, which is associated with significant reductions in liver disease and mortality. According to the authors, continued testing, treatment, and community-based interventions could move the United States closer to 2030 HCV elimination goals set by the World Health Organization (WHO) and U.S. Department of Health and Human Services (HHS) within the next decade. The findings are published in Annals of Internal Medicine.
